Condition
Eye Infections, Fungal
Total Trials
2
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
2 treatments under study, led by Voriconazole
Research Leaders
6 sponsors active, led by National Eye Institute (NEI)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
100%
2 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
2Total
Phase 3 (2)
Trial Status
Completed2
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Voriconazole2
- Natamycin1
Active Sponsors
- National Eye Institute (NEI)2
- University of California, San Francisco2
- Aravind Eye Hospitals, India2
- Dartmouth-Hitchcock Medical Center2
- Lumbini Eye Institute and Research Centre1
Top Investigators
Aravind Eye Hospitals
Proctor Foundation, UCSF
Proctor Foundation, UCSF
Related Conditions
- Corneal Ulcer2